Condition
Lymphohistiocytosis, Hemophagocytic clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Lymphohistiocytosis, Hemophagocytic clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Golidocitinib (GO) treatment for hemophagocytic lymphohistiocytosis
This trial will test whether the oral drug golidocitinib (GO) can safely treat people aged 14–70 with newly diagnosed or relapsed/refractory hemophagocytic lymphohistiocytosis who are not candidates for stem cell transplant.
-
Evaluation of secondary hemophagocytic lymphohistiocytosis and its immune mechanisms
This study is trying to understand the immune system's role in secondary hemophagocytic lymphohistiocytosis by looking closely at patients' health and blood over a year to find better treatment options.
Related topics
Quick answers
How many Lymphohistiocytosis, Hemophagocytic clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.